Get the Stockscreener App
1.90
2.70%
0.05
After Hours:
1.92
0.02
+1.05%
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Group Earnings: CEO and CFO to Unveil Full Year Performance March 20 - StockTitan
22nd Century Group, Inc. to Host Webcast on March 20, 2025, for 2024 Financial Results and Future Plans - Nasdaq
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025 - The Manila Times
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly - GlobeNewswire
22nd Century Group expands VLN products with Smoker Friendly By Investing.com - Investing.com Australia
22nd Century Group expands VLN products with Smoker Friendly - Investing.com India
22nd Century Launches Reduced Nicotine Cigarettes Through Major Partnership - StockTitan
XXII stock plunges to 52-week low, touches $3.03 amid market rout - MSN
Weiss Ratings Reiterates “Sell (E)” Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
XXII stock plunges to 52-week low of $1.72 amid market challenges - Investing.com Australia
22nd Century regains compliance with the Nasdaq - MSN
XXII stock plunges to 52-week low of $2.98 amid market challenges - Investing.com Nigeria
XXII stock plunges to 52-week low of $2.98 amid market challenges By Investing.com - Investing.com South Africa
22nd Century Group (NASDAQ:XXII) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January - Defense World
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Sells Cannabis Operations - Tobacco Reporter
Investors Buy 22nd Shares ‘Above Market’ - Tobacco Reporter
22nd Century Launches Public Offering - Tobacco Reporter
22nd Century Submits CBD Drug Master File - Tobacco Reporter
22nd Century Eliminates $2.3 million of Debt - Tobacco Reporter
22nd Century Reports Quarterly Results - Tobacco Reporter
22nd Century Group (NASDAQ: XXII) and Smoker Friendly Forge New Agreement – Market - HPBL
22nd Century Group (NASDAQ:XXII) Regains Compliance with Nasdaq Listing Rule 5550(a)(2) - Defense World
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards - The Manila Times
22nd Century Group Regains Nasdaq Compliance, Secures Exchange Listing - StockTitan
22nd Century Group Announces Strategic Agreement with Smoker Friendly – Market - HPBL
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard - The Manila Times
22nd Century Group's VLN Cigarettes Already Meet FDA's Proposed Nicotine Reduction Standard - StockTitan
22nd Century Group Resets Conversion Price in Senior Secured Credit Facility - Defense World
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):